Dr. Manar Harmouch, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,732 | 726 | 99.5% |
| Education | $56.85 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,788 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,458 | 94 | $0 (2024) |
| Amgen Inc. | $878.28 | 58 | $0 (2024) |
| Lilly USA, LLC | $783.76 | 64 | $0 (2024) |
| Merck Sharp & Dohme LLC | $745.10 | 72 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $638.52 | 37 | $0 (2023) |
| PFIZER INC. | $542.17 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $488.93 | 29 | $0 (2023) |
| EISAI INC. | $397.50 | 26 | $0 (2022) |
| GlaxoSmithKline, LLC. | $334.46 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,426 | 79 | PFIZER INC. ($186.17) |
| 2023 | $1,497 | 87 | Novo Nordisk Inc ($244.29) |
| 2022 | $858.31 | 55 | Novo Nordisk Inc ($152.15) |
| 2021 | $781.09 | 45 | Novo Nordisk Inc ($213.21) |
| 2020 | $834.70 | 58 | Novo Nordisk Inc ($220.01) |
| 2019 | $1,895 | 157 | Novo Nordisk Inc ($248.55) |
| 2018 | $1,802 | 136 | AstraZeneca Pharmaceuticals LP ($390.36) |
| 2017 | $1,695 | 116 | AstraZeneca Pharmaceuticals LP ($354.32) |
All Payment Transactions
733 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/28/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Biological | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Biological | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 377 | 543 | $125,404 | $52,099 |
| 2022 | 12 | 357 | 497 | $113,739 | $49,353 |
| 2021 | 9 | 315 | 418 | $90,887 | $41,062 |
| 2020 | 9 | 275 | 367 | $72,855 | $26,280 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 243 | $57,348 | $22,844 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $18,876 | $10,054 | 53.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 67 | $21,172 | $7,622 | 36.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $9,504 | $4,214 | 44.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,400 | $1,882 | 34.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $1,632 | $1,500 | 91.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,719 | $1,271 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,703 | $1,167 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $1,530 | $688.16 | 45.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $880.00 | $467.43 | 53.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 20 | $1,100 | $216.79 | 19.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 18 | $540.00 | $171.36 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 90 | 199 | $62,884 | $26,546 | 42.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $17,182 | $9,258 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 73 | $17,228 | $6,318 | 36.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,650 | $2,456 | 32.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 26 | 27 | $1,944 | $1,775 | 91.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 28 | $1,540 | $817.42 | 53.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $1,200 | $561.12 | 46.8% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 13 | 13 | $1,040 | $524.73 | 50.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 16 | $880.00 | $487.59 | 55.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,056 | $323.50 | 30.6% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 13 | $715.00 | $151.52 | 21.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 14 | $420.00 | $134.11 | 31.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 67 | 109 | $34,444 | $15,249 | 44.3% |
About Dr. Manar Harmouch, M.D
Dr. Manar Harmouch, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1902242563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manar Harmouch, M.D has received a total of $10,789 in payments from pharmaceutical and medical device companies, with $1,426 received in 2024. These payments were reported across 733 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,732).
As a Medicare-enrolled provider, Harmouch has provided services to 1,324 Medicare beneficiaries, totaling 1,825 services with total Medicare billing of $168,795. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Houston, TX
- Active Since 05/22/2013
- Last Updated 01/10/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1902242563
Products in Payments
- FARXIGA (Drug) $1,280
- Ozempic (Drug) $600.55
- JARDIANCE (Drug) $518.94
- JANUVIA (Drug) $421.30
- Victoza (Drug) $331.32
- TRADJENTA (Drug) $286.52
- Belviq (Drug) $283.24
- Prolia (Biological) $274.36
- FREESTYLE LIBRE 3 (Device) $259.49
- Aimovig (Biological) $219.85
- TRELEGY ELLIPTA (Drug) $218.30
- Wegovy (Drug) $217.23
- TRULICITY (Drug) $216.34
- NURTEC ODT (Drug) $209.61
- EMGALITY (Drug) $191.81
- Otezla (Drug) $180.31
- ENTRESTO (Drug) $176.92
- VRAYLAR (Drug) $170.29
- SOLIQUA (Drug) $167.25
- CAPLYTA (Drug) $163.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401